Union Medical Healthcare Limited provided unaudited earnings guidance for the six months ended 30 September 2020. The Group expects to record sales volume of no less than HKD 900 million for the period, representing a year-on-year decrease of no more than 16%. In particular, the Group recorded a sales volume of no less than HKD 460 million for the three months ended 30 June 2020 and no less than HKD 440 million for the three months ended 30 September 2020. The Group also recorded a year-on-year increase of no less than 30% in sales volume in the clinics and service centers located in Mainland China and a year-on-year increase of no less than 25% in sales volume of medical service offered for the six months ended 30 September 2020. Although the adverse economic conditions from the outbreak of COVID-19 with restrictions on cross-border passenger travelling and social distancing in Hong Kong, the Group was able to redirect its proactive client engagement and promotional campaigns to boost sales in Mainland China and local spending, and complete acquisitions of certain medical establishment. While the overall financial position of the Group remains healthy, the Group expects to record a decline in net profit for the six months ended 30 September 2020.